114 related articles for article (PubMed ID: 16717241)
1. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Groves MD
Neurology; 2006 May; 66(10):1609-10; author reply 1609-10. PubMed ID: 16717241
[No Abstract] [Full Text] [Related]
2. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Reijneveld JC; Brandsma D; Boogerd W; Bonfrer JG; Kalmijn S; Voest EE; Geurts-Moespot A; Visser MC; Taphoorn MJ
Neurology; 2005 Oct; 65(7):1120-2. PubMed ID: 16217072
[TBL] [Abstract][Full Text] [Related]
3. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
[TBL] [Abstract][Full Text] [Related]
4. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
Aviles A; Gómez R; Salas J
Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
[TBL] [Abstract][Full Text] [Related]
5. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
Eclache V; Vu T; Le Roux G
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value.
Herrlinger U; Wiendl H; Renninger M; Förschler H; Dichgans J; Weller M
Br J Cancer; 2004 Jul; 91(2):219-24. PubMed ID: 15213721
[TBL] [Abstract][Full Text] [Related]
7. [Cerebrospinal fluid cytology in meningeal invasion of leukemia and malignant lymphoma. Reliable diagnosis by immunocytochemistry].
Bamborschke S; Huber M
Nervenarzt; 1992 Apr; 63(4):218-22. PubMed ID: 1594087
[TBL] [Abstract][Full Text] [Related]
8. CSF myelin basic protein levels in leptomeningeal metastases. Relationship to disease activity.
Siegal T; Ovadia H; Yatsiv I; Abramsky O
J Neurol Sci; 1987 Apr; 78(2):165-73. PubMed ID: 2437254
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of sialic acid in the CSF; in relation to the malignancy and leptomeningeal dissemination].
Moroki K; Kuratsu J; Yoshioka S; Kohchi M; Uemura S; Matsukado Y; Ushio Y
No To Shinkei; 1989 Mar; 41(3):305-7. PubMed ID: 2757844
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
[TBL] [Abstract][Full Text] [Related]
11. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
Broussalis E; Hutterer M; Oppermann K; Wipfler P; Pilz G; Harrer A; Haschke-Becher E; Golaszewski S; Schönauer U; Weis S; Killer-Oberpfalzer M; Mc Coy M; Trinka E; Kraus J
Acta Neurol Scand; 2012 Sep; 126(3):e11-6. PubMed ID: 22211863
[TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.
Offersen BV; Pfeiffer P; Andreasen P; Overgaard J
Lung Cancer; 2007 Apr; 56(1):43-50. PubMed ID: 17207889
[TBL] [Abstract][Full Text] [Related]
13. Lactic acid concentration and acid-base balance in cerebrospinal fluid: observations of diagnostic importance in non-Hodgkin lymphoma.
Bjerrum OW; Borregaard N; Lage S
Neoplasma; 1987; 34(1):27-31. PubMed ID: 3104807
[TBL] [Abstract][Full Text] [Related]
14. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis.
Rogers LR; Duchesneau PM; Nunez C; Fishleder AJ; Weick JK; Bauer LJ; Boyett JM
Neurology; 1992 Jun; 42(6):1239-41. PubMed ID: 1603352
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL
Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070
[TBL] [Abstract][Full Text] [Related]
17. Elevated cerebrospinal fluid beta-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system.
Alsobhi EM; Hashim IA; Abdelaal MA; Aljifri AM; Alshamy AM
Saudi Med J; 2007 Jan; 28(1):128-30. PubMed ID: 17206305
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
Chamberlain MC; Glantz M; Groves MD; Wilson WH
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682
[TBL] [Abstract][Full Text] [Related]
19. Commentary regarding neoplastic meningitis secondary to multiple myeloma.
Chamberlain MC
Arch Neurol; 2005 May; 62(5):833; author reply 834. PubMed ID: 15883275
[No Abstract] [Full Text] [Related]
20. Gastric cancer with isolated leptomeningeal metastases: a case report.
Sambasivaiah K; Reddy K; Lakshmi AY; Menon B; Varma VS
Trop Gastroenterol; 2007; 28(1):39-40. PubMed ID: 17896611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]